Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 12, 2022 08:15 ET | Source: Napigen, Inc.

NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology

WILMINGTON, Del., July 12, 2022 (GLOBE NEWSWIRE) -- NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, completed a $7.85 million seed funding round. ...
January 28, 2020 08:15 ET | Source: Napigen, Inc.

NAPIGEN Publication Provides Proof of Concept of its Technology for Editing Cytoplasmic Genome (Mitochondrial and Chloroplast Genome)

WILMINGTON, Del., Jan. 28, 2020 (GLOBE NEWSWIRE) -- NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, said it demonstrated for the first time the...